You are here: All Products  > Everest Acquires China Rights to Tetraphase's Antibiotic in $23.5 Million Deal

Everest Acquires China Rights to Tetraphase's Antibiotic in $23.5 Million Deal

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products